Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small conductance chloride channel proteins are integral membrane proteins that facilitate the selective passage of chloride ions (Cl⁻) across cellular membranes. These channels play a crucial role in maintaining cellular ion homeostasis, regulating cell volume, and contributing to the electrical excitability of various cell types. Most small conductance chloride channels belong to the CLC family (Chloride Channel family). Each CLC channel is typically a homodimer, with each subunit forming its own pore for independent ion conduction. Chloride flows down its electrochemical gradient when these channels open. Dysfunction or mutations in small conductance chloride channel proteins can lead to various diseases like myotonia congenita, caused by mutations in ClC‐1. These channels can be modulated pharmacologically using drugs acting as inhibitors or activators.
Modulation of chloride ion flux across cell membranes.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small Conductance Chloride Channel Protein (SCCC).